Versant Side Fund III, L.P.
Related Filers (19)
- Versant Venture Capital III, L.P. (20)
- Versant Ventures III, LLC (10)
- Trius Therapeutics Inc (7)
- OCULAR THERAPEUTIX, INC (7)
- ATWOOD BRIAN G (6)
- VERACYTE, INC. (6)
- MILDER DONALD B (5)
- COLELLA SAMUEL D (5)
- JAFFE ROSS A MD (5)
- LINK WILLIAM J PHD (5)
- Flexion Therapeutics Inc (4)
- LUBASH BARBARA N (4)
- PHASERX, INC. (3)
- Praeger Robin L. (3)
- Versant Development Fund III, L.P. (3)
- Immune Design Corp. (2)
- ROBERTSON REBECCA B (2)
- OPGEN INC (2)
- Skye Bioscience, Inc. (1)
- Show More ...
Ownership (32)
3
Monday, 8/28/2023
Skye Bioscience, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Friday, 2/14/2020
VERACYTE, INC.: Major Shareholders
SC 13G/A
Friday, 2/14/2020
OCULAR THERAPEUTIX, INC: Major Shareholders
4
Friday, 6/10/2016
Flexion Therapeutics Inc: Statement of changes in beneficial ownership of securities
3/A
Tuesday, 5/24/2016
PHASERX, INC.: Initial statement of beneficial ownership of securities
4
Tuesday, 5/24/2016
PHASERX, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/17/2016
PHASERX, INC.: Initial statement of beneficial ownership of securities
SC 13G/A
Wednesday, 2/10/2016
VERACYTE, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/10/2016
OCULAR THERAPEUTIX, INC: Major Shareholders
4
Monday, 6/15/2015
OCULAR THERAPEUTIX, INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/11/2015
OCULAR THERAPEUTIX, INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/12/2015
OPGEN INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/6/2015
OPGEN INC: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/17/2015
VERACYTE, INC.: Major Shareholders
SC 13G
Tuesday, 2/17/2015
OCULAR THERAPEUTIX, INC: Major Shareholders
4
Friday, 9/12/2014
Flexion Therapeutics Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 7/31/2014
OCULAR THERAPEUTIX, INC: Statement of changes in beneficial ownership of securities
4
Thursday, 7/31/2014
Immune Design Corp.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/24/2014
OCULAR THERAPEUTIX, INC: Initial statement of beneficial ownership of securities
3
Wednesday, 7/23/2014
Immune Design Corp.: Initial statement of beneficial ownership of securities
4
Thursday, 2/20/2014
Flexion Therapeutics Inc: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 2/13/2014
VERACYTE, INC.: Major Shareholders
3
Tuesday, 2/11/2014
Flexion Therapeutics Inc: Initial statement of beneficial ownership of securities
4
Monday, 11/4/2013
VERACYTE, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/29/2013
VERACYTE, INC.: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 2/11/2013
Trius Therapeutics Inc: Major Shareholders
SC 13G/A
Tuesday, 5/8/2012
Trius Therapeutics Inc: Major Shareholders
SC 13G/A
Friday, 2/10/2012
Trius Therapeutics Inc: Major Shareholders
SC 13G/A
Monday, 6/6/2011
Trius Therapeutics Inc: Major Shareholders
SC 13G
Monday, 2/14/2011
Trius Therapeutics Inc: Major Shareholders
4
Tuesday, 8/10/2010
Trius Therapeutics Inc: Statement of changes in beneficial ownership of securities
3
Monday, 8/2/2010
Trius Therapeutics Inc: Initial statement of beneficial ownership of securities